• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Iron Infusion Boosts Exercise Capacity in Heart Failure Patients

by
November 8, 2026
in Health
Reading Time: 3 mins read
0
Iron Infusion Boosts Exercise Capacity in Heart Failure Patients

Iron Infusion Boosts Exercise Capacity in Heart Failure Patients

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A randomized clinical trial conducted by investigators at the Mass General Brigham Heart and Vascular Institute has demonstrated that a single intravenous iron infusion significantly improves exercise capacity in individuals suffering from heart failure with preserved ejection fraction (HFpEF) and concurrent iron deficiency. The study, known as the IRON-MET HFpEF trial, provides the first comprehensive evaluation of exercise response patterns to iron repletion in this specific patient population. The findings, presented at the 2026 American Heart Association Scientific Sessions and published simultaneously in the journal Circulation, suggest that replenishing iron stores may help address the severe physical limitations associated with this common form of heart failure.

Heart failure with preserved ejection fraction is a prevalent condition that places a significant burden on patients due to severe limitations in exercise tolerance. Iron deficiency is a frequent comorbidity, affecting more than 50% of patients with HFpEF. The research team aimed to determine whether correcting this deficiency through intravenous administration could yield functional benefits. Lead author Gregory D. Lewis, MD, director of Heart Failure at the Mass General Brigham Heart and Vascular Institute and professor of Medicine at Harvard Medical School, noted that the study was designed to comprehensively evaluate how iron repletion impacts exercise capacity in these patients.

The trial enrolled 65 participants with symptomatic HFpEF and confirmed iron deficiency. The cohort had a median age of 68 years, and 72% of the participants were women. Participants were randomized into two groups: 44 received a single 1,000-mg intravenous dose of ferric derisomaltose, while 21 received a placebo. The decision to use intravenous iron rather than oral supplementation was based on previous studies demonstrating that oral iron is not beneficial in patients with other forms of heart failure, likely due to poor gastrointestinal absorption.

All participants underwent cardiopulmonary exercise testing both before the intervention and 12 weeks after the infusion. The primary outcome measured was peak oxygen uptake, or VO2, which serves as a key indicator of cardiorespiratory fitness. At the 12-week mark, the intervention group showed an improvement of approximately 10% in peak VO2. In contrast, the placebo group experienced no change in this metric.

In addition to the primary outcome, the study evaluated several pre-specified secondary measures of exercise capacity. These included the 6-minute walk distance, VO2 at the anaerobic threshold, and the New York Heart Association Functional Class. Measurements of iron bioavailability in the blood also improved in the group receiving intravenous iron compared to the placebo group. These secondary endpoints further support the conclusion that ferric derisomaltose improved multiple aspects of exercise capacity.

However, the study also noted that patient-reported health scores, which were based on a comprehensive questionnaire, did not differ significantly between the two groups. Senior author Rajeev Malhotra, MD, Associate Director of the Cardiopulmonary Exercise Laboratory at the Mass General Brigham Heart and Vascular Institute and associate professor of Medicine at Harvard Medical School, emphasized that the observed improvement in peak VO2 represents a clinically meaningful increment for patients with heart failure.

The safety profile of the intervention was also assessed, with no serious adverse events associated with the iron supplementation. Nevertheless, the authors acknowledge several limitations in the study design. The trial was conducted in a small, predominantly white population, which may limit the generalizability of the findings to more diverse groups. Additionally, the assessment period was limited to 12 weeks, leaving questions about the durability of the benefits over longer time periods.

Given these limitations, the authors advocate for further studies to determine whether intravenous iron provides benefits in diverse populations and whether the observed improvements in exercise capacity persist over extended durations. The next step in the research, according to Malhotra, is to determine whether IV iron can improve long-term clinical outcomes in patients with HFpEF. The study was funded by the National Heart, Lung, and Blood Institute, and the authors disclosed that Lewis and Malhotra have served as advisors for Pharmacosmos, with Lewis having previously served on the scientific advisory board for American Regent.

Subject of Research: Single iron infusion improved exercise capacity in people with the most common form of heart failure

Article Title: Single iron infusion improved exercise capacity in people with the most common form of heart failure

Article References: Single iron infusion improved exercise capacity in people with the most common form of heart failure. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: Single, iron, infusion, improved, exercise, capacity, people, most, common, form, heart, failure

News Source: Ophelia Keating. (November 8, 2026). Iron Infusion Boosts Exercise Capacity in Heart Failure Patients. Scienmag.

Tags: capacitycommonExercisefailureFormheartimprovedinfusionironmostpeoplesingle
Share12Tweet7Share2ShareShareShare1

Related Posts

Study Maps Photon Interaction Parameters and Electron Density for PET Radiotracer FDG

Study Maps Photon Interaction Parameters and Electron Density for PET Radiotracer FDG

November 20, 2026
Robotic Biopsy System Learns Expert Physician Skills to Improve Needle Insertion Accuracy

Robotic Biopsy System Learns Expert Physician Skills to Improve Needle Insertion Accuracy

November 20, 2026

COVID-19 Linked to Higher Healthcare Burden in Rare Disease Patients in Germany

November 20, 2026

WHO Survey Analysis Finds Widespread Low DASH Dietary Consistency Across Africa

November 20, 2026

POPULAR NEWS

  • Cardiovascular Review Examines Microplastics Evidence Across Human Tissues and Coronary Disease

    Cardiovascular Review Examines Microplastics Evidence Across Human Tissues and Coronary Disease

    29 shares
    Share 12 Tweet 7
  • New Estimand Framework Clarifies Model Validation and Data Splitting in Predictive Modelling

    29 shares
    Share 12 Tweet 7
  • Rare Periorbital Inflammation Reported After Subconjunctival Mitomycin C in Glaucoma Procedures

    29 shares
    Share 12 Tweet 7
  • Hands-On Workshops Sharply Increase Livestock Stakeholder Foot-And-Mouth Disease Recognition in Puerto Rico

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Study Maps Photon Interaction Parameters and Electron Density for PET Radiotracer FDG

Robotic Biopsy System Learns Expert Physician Skills to Improve Needle Insertion Accuracy

Multiple Myeloma Patients in Middle East Diagnosed Younger Than Global Average

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.